Literature DB >> 4611742

Prostaglandins: pharmacology and clinical application.

S M Karim, K Hillier.   

Abstract

Entities:  

Keywords:  Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Abortion, Spontaneous; Biology; Coitus; Delivery; Demographic Factors; Diseases; Endocrine System; Family Planning; Fertility; Fertility Control, Postconception; Fertilization; Literature Review; Men; Menstruation; Ovulation; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Complications; Pregnancy Outcomes; Prostaglandins--analysis; Prostaglandins--pharmacodynamics; Reproduction; Sperm Transport; Women

Mesh：

Substances：

Year:  1974        PMID： 4611742     DOI： 10.2165/00003495-197408030-00004

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  121 in total

1.  Effect of prostaglandin E 1 on leukocyte migration.

Authors:  G Kaley; R Weiner
Journal:  Nat New Biol       Date:  1971-11-24

2.  "Delayed menstruation" induced by prostaglandin in pregnant patients.

Authors:  P Mocsary; A I Csapo
Journal:  Lancet       Date:  1973-09-22       Impact factor: 79.321

3.  Letter: Early abortion induced with prostaglandin F2a and a prostaglandin analogue I.C.I. 74,205.

Authors:  M P Embrey; K Hillier; A A Calder
Journal:  Lancet       Date:  1973-11-10       Impact factor: 79.321

4.  Adenosine 3',5' monophosphate as an inhibitor of ovulation and reproduction.

Authors:  W L Ryan; D M Coronel
Journal:  Am J Obstet Gynecol       Date:  1969-09-01       Impact factor: 8.661

5.  The physiological role of prostaglandin F2alpha in corpus luteum regression.

Authors:  J A McCracken; B Barcikowski; J C Carlson; K Gréen; B Samuelsson
Journal:  Adv Biosci       Date:  1973

6.  The use of prostaglandin E 2 for therapeutic abortion.

Authors:  S M Karim; G M Filshie
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-01

7.  Vascular control of luteal steroidogenesis.

Authors:  B B Pharriss; J C Cornette; G D Gutknecht
Journal:  J Reprod Fertil Suppl       Date:  1970

8.  Effect of prostaglandin E1 on the midpregnant human uterus. Intravenous, intramuscular, intra-amniotic, and vaginal administration.

Authors:  N Wiqvist; M Bygdeman; S U Kwon; T Mukherjee; U Roth-Brandel
Journal:  Am J Obstet Gynecol       Date:  1968-10-01       Impact factor: 8.661

9.  A simple chemical procedure for distinguishing E from F prostaglandins, with application to tissue extracts.

Authors:  N Ambache; H C Brummer
Journal:  Br J Pharmacol Chemother       Date:  1968-05

10.  The use of prostaglandin E 2 in the management of intrauterine death, missed abortion and hydatidiform mole.

Authors:  G M Filshie
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-01
View more
  4 in total

1.  Naproxen: a review of its pharmacological properties and therapeutic efficacy and use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 2.  Mechanisms of action of gold.

Authors:  J H Leibfarth; R H Persellin
Journal:  Agents Actions       Date:  1981-11

3.  Prostaglandins and ocular inflammation.

Authors:  D W Hall; I L Bonta
Journal:  Doc Ophthalmol       Date:  1977-12-30       Impact factor: 2.379

Review 4.  Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.